Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul;70(4):628-35.
doi: 10.15288/jsad.2009.70.628.

Counselor attitudes toward pharmacotherapies for alcohol dependence

Amanda J Abraham  1 , Lori J Ducharme, Paul M Roman
Affiliations

Counselor attitudes toward pharmacotherapies for alcohol dependence

Amanda J Abraham et al. J Stud Alcohol Drugs. 2009 Jul.

Abstract

Objective: Addiction treatment counselors play a central role in the dissemination of information about new treatment techniques to alcohol-dependent patients and are key in the implementation of new treatment technologies. Building on previous research, this study examines counselors' perceptions of the effectiveness and acceptability of pharmacotherapies for the treatment of alcohol dependence.

Method: Mail questionnaires were received from 1,140 counselors employed in a nationally representative sample of public-sector addiction treatment programs in 2006. Counselors answered a series of questions about three U.S. Food and Drug Administration (FDA)-approved medications used in the treatment of alcohol dependence (disulfiram [Antabuse], tablet naltrexone [Revia], and acamprosate [Campral]), indicating their extent of familiarity with the medication, its perceived effectiveness in the treatment of alcohol dependence, and its acceptability for use with alcohol-dependent patients.

Results: The extent of diffusion of these pharmacotherapies was associated with time since FDA approval. Counselors reported receiving little or no pharmacotherapy-specific training. Multivariate models showed that the receipt of medication-specific training as well as indirect observation of the medication's use in the treatment program were significantly associated with diffusion of information about these pharmacotherapies and counselors' perceptions of the effectiveness and acceptability of the medications for use in addiction treatment.

Conclusions: When exposed to information about medications to treat alcohol dependence, counseling staff appear quite receptive. More efforts are needed to disseminate information about alcohol pharmacotherapies to front-line addiction treatment staff.

PubMed Disclaimer

References

    1. Center for Substance Abuse Treatment. Naltrexone and Alcoholism Treatment. Treatment Improvement Protocol (TIP) Series 28, DHHS Publication No. (SMA) 98–3206. Rockville, MD: Substance Abuse and Mental Health Services Administration; 1998. - PubMed
    1. Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43, DHHS Publication No. (SMA) 05–4048. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. - PubMed
    1. Ducharme LJ, Knudsen HK, Roman PM. Trends in the adoption of medications for alcohol dependence. J. Clin. Psychopharmacol. 2006;26(Suppl.No. 1):S13–S19. - PubMed
    1. Forman RF, Bovasso G, Woody G. Staff beliefs about addiction treatment. J. Subst. Abuse Treat. 2001;21:1–9. - PubMed
    1. Fuller BE, Rieckmann T, McCarty D, Smith KW, Levine H. Adoption of naltrexone to treat alcohol dependence. J. Subst. Abuse Treat. 2005;28:273–280. - PubMed

Publication types